Erin Simonds

Erin Simonds is the Executive Director of Discovery Biology at Lilly Oncology, where they lead the discovery and early validation of oncology targets. With 17 years of experience in cancer research, Erin has a strong background in large molecule drugs and immunotherapy. They previously worked as a Director of Immuno-Oncology at Soteria Biotherapeutics, overseeing preclinical development, and have held positions as a postdoctoral fellow and adjunct faculty member at the University of California, San Francisco. Erin earned a BS in Cellular and Molecular Biology from the University of Connecticut and a PhD in Microbiology & Immunology from Stanford University.